Navigation Links
Medrio Announces Advanced Research Associates to Join Partner Program
Date:11/26/2013

San Francisco, CA (PRWEB) November 26, 2013

Medrio, a leading provider of Electronic Data Capture (EDC) software via an eClinical Software as a Service (SaaS) suite, proudly announces that Advanced Research Associates (ARA), a trusted clinical research partner to the pharmaceutical, biotech, and medical device industries, is the latest CRO to join Medrio’s Partner Program.

“We are excited about the partnership of Medrio’s powerful EDC software with ARA’s innovative clinical research solutions,” said Scott Weidley, Senior Director of Sales and Marketing at Medrio. “Over the years we’ve worked closely with ARA, having done more than 30 studies together, and look forward to continuing this collaboration through our partnership.”

“Medrio has been ARA’s preferred EDC vendor for over four years,” said Peter Shabe, Founder and President of Advanced Research Associates. “We both believe strongly in elevating the customer experience so we are thrilled to grow our partnership and win more business together.”

About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit http://www.medrio.com.

About Advanced Research Associates
Founded in 1996, Advance Research Associates has become a trusted clinical research partner to the pharmaceutical, biotech, and medical device industries. In the years since its inception, ARA has provided a spectrum of innovative solutions and lent its expertise across a wide range of projects.
While these customized solutions are always based entirely on client need, the success of any project hinges on the strength of the personal relationship developed between client and partner through daily communication. ARA's collaborative management philosophy supports extensive interaction, resulting in clients consistently achieving their highest objectives.

With more than 75 years of collective practical clinical research experience, the seasoned ARA staff has the right skills to successfully manage your next clinical research program. http://www.advanceresearch.com

Read the full story at http://www.prweb.com/releases/eClinicalsoftware/eClinicaltools/prweb11368506.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Veracity Logic and Medrio Announce Real Time Interface
2. Medrio, a Leading EDC Provider for Clinical Research, Announces Its Latest Version, 8.1 with iPad Support, is Available Without Charge for Academic Researchers
3. Provonix Joins the Medrio Partner Program
4. Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
5. Medrio Electronic Data Capture Software for Clinical Trials is Now Available without Charge to Universities
6. Sangamo BioSciences Announces Presentation At The 25th Annual Piper Jaffray Healthcare Conference
7. Elsevier Announces the Launch of Open Access Journal: Case Studies in Construction Materials
8. RPS Announces FDA Clearance of Rapid, Point-of-Care Test for Dry Eye Disease – InflammaDry®
9. Goodmark Medical announces joining the American Chiropractic Association’s (ACA) Corporate Member Program
10. ISPE Announces Recipients of 2013 International Honor Awards at Global Annual Meeting
11. Ceres Announces Fiscal Year 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):